Richard G Jarman, Iii

Title: Richard G. Jarman, III: Innovator in Monoclonal Antibodies

Introduction

Richard G. Jarman, III is a notable inventor based in Silver Spring, MD, who has made significant contributions to the field of medical science. His work primarily focuses on developing innovative solutions to combat viral infections, particularly those caused by the Zika virus.

Latest Patents

Jarman holds a patent for "Potent Zika virus-specific and cross-neutralizing monoclonal antibodies to Zika and dengue viruses following ZIKV infection or vaccination." This invention provides antibodies that are useful in treating or preventing Zika virus infections. The novel polypeptides described in the patent can be utilized alone or as components of larger molecules, such as antibodies or antibody fragments.

Career Highlights

Throughout his career, Richard has worked with esteemed organizations, including the Henry M. Jackson Foundation for the Advancement of Military Medicine and Beth Israel Deaconess Medical Center. His experience in these institutions has allowed him to contribute to important research and development in the medical field.

Collaborations

Richard has collaborated with several professionals in his field, including Shelly Krebs and Gina Donofrio. These partnerships have enhanced his research efforts and have been instrumental in advancing his work on monoclonal antibodies.

Conclusion

Richard G. Jarman, III is a distinguished inventor whose work on monoclonal antibodies represents a significant advancement in the fight against viral infections. His contributions continue to impact the medical community positively.